{
  "ticker": "CATX",
  "company_name": "Perspective Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05111509",
      "title": "A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "EARLY_PHASE1",
      "condition": "Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1",
      "start_date": "2022-08-22",
      "completion_date": "2026-06-30",
      "enrollment": 0,
      "sponsor": "Yusuf Menda"
    },
    {
      "nct_id": "NCT04904120",
      "title": "Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal, Melanoma, Mucosal",
      "start_date": "2021-03-05",
      "completion_date": "2022-09-20",
      "enrollment": 0,
      "sponsor": "Perspective Therapeutics"
    },
    {
      "nct_id": "NCT05636618",
      "title": "Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic, Gastroenteropancreatic Neuroendocrine Tumor, Bronchial Neuroendocrine Tumor, Paraganglioma, Pheochromocytoma",
      "start_date": "2023-09-27",
      "completion_date": "2029-12-26",
      "enrollment": 0,
      "sponsor": "Perspective Therapeutics"
    },
    {
      "nct_id": "NCT06148636",
      "title": "A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "EARLY_PHASE1",
      "condition": "Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1, Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor of Pancreas",
      "start_date": "2023-11-10",
      "completion_date": "2027-12-31",
      "enrollment": 0,
      "sponsor": "David Bushnell"
    },
    {
      "nct_id": "NCT06710756",
      "title": "Lead-212 PSV359 Therapy for Patients With Solid Tumors",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Pancreatic Ductal Adenocarcinoma, Gastric Cancer, Esophageal Cancer, Colorectal Cancer, Ovarian Cancer, Head and Neck Cancer, Sarcoma, Mesothelioma",
      "start_date": "2025-04-28",
      "completion_date": "2032-05-28",
      "enrollment": 0,
      "sponsor": "Perspective Therapeutics"
    },
    {
      "nct_id": "NCT05655312",
      "title": "MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Recurrent Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV, Melanoma Stage III",
      "start_date": "2023-06-01",
      "completion_date": "2029-12-31",
      "enrollment": 0,
      "sponsor": "Perspective Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 6,
    "by_phase": {
      "EARLY_PHASE1": 2,
      "PHASE1": 1,
      "PHASE1, PHASE2": 3
    },
    "by_status": {
      "ACTIVE_NOT_RECRUITING": 2,
      "COMPLETED": 1,
      "RECRUITING": 3
    },
    "active_trials": 5,
    "completed_trials": 1,
    "conditions": [
      "Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal, Melanoma, Mucosal",
      "Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1",
      "Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic, Gastroenteropancreatic Neuroendocrine Tumor, Bronchial Neuroendocrine Tumor, Paraganglioma, Pheochromocytoma",
      "Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1, Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor of Pancreas",
      "Pancreatic Ductal Adenocarcinoma, Gastric Cancer, Esophageal Cancer, Colorectal Cancer, Ovarian Cancer, Head and Neck Cancer, Sarcoma, Mesothelioma",
      "Recurrent Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV, Melanoma Stage III"
    ],
    "lead_stage": "phase_1"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:20.194580",
    "search_query": "Perspective Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Perspective+Therapeutics,+Inc."
  }
}